Home » Topics » BioWorld Science

BioWorld Science
RSS

Sterinetics System successfully inactivates multiple viruses in IVIg

Dec. 5, 1996

RTP to accelerate development of insoluble drug delivery technology

Dec. 5, 1996

Priority review for Crinone

Dec. 5, 1996

Incyte and Abbott expand genomic database agreement

Dec. 5, 1996

E-Z-EM introduces new dysphagia diagnostic kit

Dec. 5, 1996

Patent issued for Vical's core technology

Dec. 5, 1996

New company formed with focus on women's health

Dec. 5, 1996

Phase IIa trial on Isis antiinflammatory antisense compound completed

Dec. 5, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

Antitumor enhancers claimed by Taiho

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...